Cardiac Troponin T and Troponin I in the General Population
Paul Welsh1, David Preiss2, Caroline Hayward3
1Institute of Cardiovascular and Medical Sciences (P.W., S.P., C.W., N.S.), University of Glasgow, United Kingdom.
Insights
High-sensitivity cardiac troponin I (cTnI) and cardiac troponin T (cTnT) have different associations with cardiovascular disease (CVD) and non-CVD mortality. cTnI is more linked to CVD events, while cTnT predicts non-CVD death, informing assay selection.
Area of Science:
- Cardiology
- Genetics
- Biomarkers
Background:
- High-sensitivity cardiac troponins (hs-cTn) are increasingly used for population screening of cardiovascular disease (CVD) and heart failure.
- The equivalence of cardiac troponin T (cTnT) and cardiac troponin I (cTnI) as risk markers in this context is not established.
Purpose of the Study:
- To compare the associations of cTnT and cTnI with CVD and non-CVD outcomes.
- To investigate the genetic determinants of cTnT and cTnI levels through a genome-wide association study.
Main Methods:
- hs-cTnT and hs-cTnI levels were measured in 19,501 individuals from the Generation Scotland Scottish Family Health Study.
- Cox proportional hazards models were used to assess associations with composite CVD outcomes, CVD death, non-CVD death, and heart failure over a median follow-up of 7.8 years.
- Genome-wide association studies (GWAS) were performed to identify genetic loci associated with each troponin type.
Main Results:
- Both cTnI and cTnT were associated with CVD risk. After adjustment for risk factors, cTnI showed a stronger association with CVD outcomes (HR 1.24) than cTnT (HR 1.11).
- cTnI was specifically linked to myocardial infarction and coronary heart disease, while cTnT was associated with non-CVD mortality (HR 0.77).
- GWAS identified distinct genetic loci associated with cTnI (5 loci) and cTnT (4 loci).
Conclusions:
- The genetic underpinnings and prognostic associations of cTnI and cTnT differ significantly.
- cTnI elevations are more indicative of CVD risk, whereas cTnT elevations are more associated with non-CVD mortality.
- These findings have implications for selecting appropriate troponin assays for clinical practice and research.
Background:
There is great interest in widening the use of high-sensitivity cardiac troponins for population cardiovascular disease (CVD) and heart failure screening. However, it is not clear whether cardiac troponin T (cTnT) and troponin I (cTnI) are equivalent measures of risk in this setting. We aimed to compare and contrast (1) the association of cTnT and cTnI with CVD and non-CVD outcomes, and (2) their determinants in a genome-wide association study.
Methods:
High-sensitivity cTnT and cTnI were measured in serum from 19 501 individuals in Generation Scotland Scottish Family Health Study. Median follow-up was 7.8 years (quartile 1 to quartile 3, 7.1-9.2). Associations of each troponin with a composite CVD outcome (1177 events), CVD death (n=266), non-CVD death (n=374), and heart failure (n=216) were determined by using Cox models. A genome-wide association study was conducted using a standard approach developed for the cohort.
Results:
Both cTnI and cTnT were strongly associated with CVD risk in unadjusted models. After adjusting for classical risk factors, the hazard ratio for a 1 SD increase in log transformed troponin was 1.24 (95% CI, 1.17-1.32) and 1.11 (1.04-1.19) for cTnI and cTnT, respectively; ratio of hazard ratios 1.12 (1.04-1.21). cTnI, but not cTnT, was associated with myocardial infarction and coronary heart disease. Both cTnI and cTnT had strong associations with CVD death and heart failure. By contrast, cTnT, but not cTnI, was associated with non-CVD death; ratio of hazard ratios 0.77 (0.67-0.88). We identified 5 loci (53 individual single-nucleotide polymorphisms) that had genome-wide significant associations with cTnI, and a different set of 4 loci (4 single-nucleotide polymorphisms) for cTnT.
Conclusions:
The upstream genetic causes of low-grade elevations in cTnI and cTnT appear distinct, and their associations with outcomes also differ. Elevations in cTnI are more strongly associated with some CVD outcomes, whereas cTnT is more strongly associated with the risk of non-CVD death. These findings help inform the selection of an optimal troponin assay for future clinical care and research in this setting.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
04:40Creation of Cardiac Tissue Exhibiting Mechanical Integration of Spheroids Using 3D Bioprinting
Published on: July 2, 2017
Related Concept Videos
Conservation of Small Populations
What is Population Genetics?
Population Growth
What are Populations and Communities?
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Conservation of Declining Populations
